Salient features :
This article focusses on :
- Strategy for areas reporting clusters (containment zone) and in large migration gatherings/evacuees centres
- General guidelines to be followed by the healthcare workers while doing rapid antibody tests
Detailed summary :
Strategy for areas reporting clusters (containment zone) and in large migration gatherings/evacuees centres
- Cases of Influenza Like Illness (ILI) should be monitored in health facilities.
- Any surge in cases should be monitored and brought to the notice of Surveillance Officer/CMO for additional investigation.
- All symptomatic ILI persons should be home quarantined for 14 days.
- All symptomatic ILI individuals should be tested using rapid antibody tests.
Antibody test negative
- confirm with real-time RT-PCR using throat/nasal swab.
- RT-PCR negative: Likely non-COVID-19 ILI
- RT-PCR positive: Confirmed COVID-19
- If real-time RT-PCR not done, individual should be home quarantined and after 10 days antibody testing should be repeated.
- Antibody test negative: Likely non-COVID-19 ILI.
- Antibody test positive: there is possibility of recent infection quarantine for another 10 days.
Antibody test positive: After clinical assessment, treatment in hospital or isolation should be followed as per protocol. Action should be initiated for contact tracing.
- If symptoms worsen,the patient should be refered to designated COVID-19 hospitals.
General guidelines to be followed by the healrhcare workers while doing rapid antibody tests
- Gloves, mask, and head covers should be used.
- HCW’s collecting throat/nasal swab should follow standard national infection control guidelines.
- The rapid antibody tests approved by US-FDA/CE-IVD or non-CE-IVD validated by ICMR-NIV with marketing approval by DCGI should be used.
- Details of all test results should be uploaded in ICMR portal to ensure that all cases are monitored and necessary actions are initiated with respect to infectious disease management.